Ultherapy™ Treatment Following Sculptra® Treatment

• Status: Completed
• Trial end date: 2012-09-01
• Target enrollment: 0
• Participant gender: All

Summary

This clinical trial will evaluate clinical outcomes associated with the non-invasive Ultherapy™ treatment to improve skin laxity and tightening following a Sculptra® treatment.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Ulthera, Inc
• Treatments: Mannitol

Criteria

Inclusion Criteria:

• Male or female, aged 35 to 60 years.

• Subject in good health.

• Skin laxity in the lower face and neck.

• Grade 1 and 2 on the Knize Scale

Exclusion Criteria:

• Presence of an active systemic or local skin disease that may affect wound healing.

• Severe solar elastosis.

• Excessive subcutaneous fat in the face and neck.

• Excessive skin laxity on the face and neck.

• No scarring in areas to be treated.

• Any open facial wounds or lesions.

• Acne on the face.

• Patients who have a history with keloid formation or hypertropic scarring

• Patients who have a hypersensitivity to injectable poly-L-lactic acid

• Presence of a metal stent or implant in the facial area to be treated.